Cannabis
Microdose Psychedelic Insights Announces Successful Launch of Wonderland: Miami
Miami, Florida–(Newsfile Corp. – November 9, 2021) – Microdose Psychedelic Insights is proud to announce the successful launch of the psychedelic medicine industry’s premiere in-person event.
Day one of Wonderland was a huge success. World class researchers, heavyweight celebrities like Mike Tyson, and countless entrepreneurs, advocates and investors. The psychedelic medicine industry has officially arrived.
Running from November 8-9, 2021 in Miami, Florida at the Adrienne Arsht Center for the Performing Arts, Wonderland is an impressive collection of global psychedelic medicine leaders, from scientists and researchers, investors and entrepreneurs, therapists and patients, government officials and media, all championing the growth of the psychedelic medicine industry.
Wonderland day one highlights included:
● Cybin hosting a press conference announcing impressive of their new drug candidate CYB-003
● Daniel Carcillo, former professional hockey player and CEO of Wesana Health sat down for a fireside chat with boxing great Mike Tyson for an inspirational talk about the life-changing effects of psychedelics
● Robin Carhart-Harris, Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape, UCSF
● Rick Doblin from MAPS in conversation with Microdose CEO Patrick Moher
● Panels included The Pathway to Federal Acceptance, Precision Medicine and Psychedelics, Next-Generation Psychedelics, and many others
The Adrienne Arsht Center was filled with innovative exhibitors, industry-leading sponsors, and entrepreneurs and investors meeting in-person and blazing new paths for the entire industry.
Wonderland day two will continue with:
● Dr. Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins
● Wonderful panels including: Evolution of Ibogaine Treatment, Psilocybin for Smoking Cessation, Investing the Shamanic Way, Patent Wars, Finance and Psychedelics
About Microdose Psychedelics Insights
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine.
For more information, please visit https://microdose.buzz/wonderland
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/102623
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth